GlassScriptPhysician profile
Charles Gary Lodge
NPI 1366521205
$1,651.40
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $588 · 2021: $540 · 2022: $22.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.96 | 2019-2021 | |
| Abbvie INC. | $184.04 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $168.33 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.25 | 2019-2021 | |
| Allergan, INC. | $131.23 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $80.72 | 2019-2021 | |
| Glaxosmithkline, LLC. | $72.29 | 2020-2021 | |
| Pfizer INC. | $66.30 | 2019-2021 | |
| Janssen Biotech, INC. | $56.27 | 2020 | |
| Lilly USA, LLC | $50.58 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $49.96 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $41.84 | 2020-2021 | |
| Amgen INC. | $38.67 | 2019 | |
| Supernus Pharmaceuticals, INC. | $26.11 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $24.78 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $22.93 | 2021 | |
| Viiv Healthcare Company | $20.45 | 2020 | |
| Gilead Sciences, INC. | $19.08 | 2019 | |
| Ironshore Pharmaceuticals INC. | $15.78 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.63 | 2021 | |
| Amarin Pharma, INC. | $13.95 | 2019 | |
| Sanofi Pasteur INC. | $13.67 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.52 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.